Cargando…

Toward precision medicine in myotonic syndromes

Detalles Bibliográficos
Autores principales:	De Bellis, Michela, Camerino, Diana Conte, Desaphy, Jean-François
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Editorial: Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5362403/ https://www.ncbi.nlm.nih.gov/pubmed/28199958 http://dx.doi.org/10.18632/oncotarget.15263

Ejemplares similares

In vivo longitudinal study of rodent skeletal muscle atrophy using ultrasonography
por: Mele, Antonietta, et al.
Publicado: (2016)

ClC-1 chloride channels: state-of-the-art research and future challenges
por: Imbrici, Paola, et al.
Publicado: (2015)

Grand Challenge for Ion Channels: an Underexploited Resource for Therapeutics
por: Camerino, Diana Conte, et al.
Publicado: (2010)

Searching for novel anti-myotonic agents: Pharmacophore requirement for use-dependent block of skeletal muscle sodium channels by N-benzylated cyclic derivatives of tocainide
por: De Luca, Annamaria, et al.
Publicado: (2012)

Therapeutic Approaches to Genetic Ion Channelopathies and Perspectives in Drug Discovery
por: Imbrici, Paola, et al.
Publicado: (2016)

In vivo evaluation of antimyotonic efficacy of β-adrenergic drugs in a rat model of myotonia
por: Desaphy, Jean-François, et al.
Publicado: (2013)

Preclinical evaluation of marketed sodium channel blockers in a rat model of myotonia discloses promising antimyotonic drugs
por: Desaphy, Jean-François, et al.
Publicado: (2014)

Dramatic improvement of myotonia permanens with flecainide: a two-case report of a possible bench-to-bedside pharmacogenetics strategy
por: Desaphy, Jean-François, et al.
Publicado: (2012)

Targeted Therapies for Skeletal Muscle Ion Channelopathies: Systematic Review and Steps Towards Precision Medicine
por: Desaphy, Jean-François, et al.
Publicado: (2021)

Dual Action of Mexiletine and Its Pyrroline Derivatives as Skeletal Muscle Sodium Channel Blockers and Anti-oxidant Compounds: Toward Novel Therapeutic Potential
por: De Bellis, Michela, et al.
Publicado: (2018)

Effects of Nandrolone in the Counteraction of Skeletal Muscle Atrophy in a Mouse Model of Muscle Disuse: Molecular Biology and Functional Evaluation
por: Camerino, Giulia Maria, et al.
Publicado: (2015)

Increased sodium channel use-dependent inhibition by a new potent analogue of tocainide greatly enhances in vivo antimyotonic activity
por: De Bellis, Michela, et al.
Publicado: (2017)

Paracrine Effects of IGF-1 Overexpression on the Functional Decline Due to Skeletal Muscle Disuse: Molecular and Functional Evaluation in Hindlimb Unloaded MLC/mIgf-1 Transgenic Mice
por: Pierno, Sabata, et al.
Publicado: (2013)

Toward Precision Medicine in ADHD
por: Buitelaar, Jan, et al.
Publicado: (2022)

Towards precision medicine for sepsis patients
por: Pickkers, Peter, et al.
Publicado: (2017)

Towards precision medicine in thyroid cancer
por: Xiao, Haipeng, et al.
Publicado: (2020)

A decade of Genome Medicine: toward precision medicine
por: Begum, Rabia
Publicado: (2019)

Elucidating the Contribution of Skeletal Muscle Ion Channels to Amyotrophic Lateral Sclerosis in search of new therapeutic options
por: Camerino, Giulia Maria, et al.
Publicado: (2019)

Clinical, Molecular, and Functional Characterization of CLCN1 Mutations in Three Families with Recessive Myotonia Congenita
por: Portaro, Simona, et al.
Publicado: (2015)

Effects of Pleiotrophin Overexpression on Mouse Skeletal Muscles in Normal Loading and in Actual and Simulated Microgravity
por: Camerino, Giulia Maria, et al.
Publicado: (2013)

Toward Precision Medicine: How Far Is the Goal?
por: Ravegnini, Gloria, et al.
Publicado: (2016)

Synthetic human leukemia models: towards precision medicine
por: Cellot, Sonia, et al.
Publicado: (2017)

Towards precision medicine in colorectal cancer liver metastases
por: O’Connor, Juan Manuel, et al.
Publicado: (2020)

Towards the era of precision medicine in metastatic colorectal cancer
por: Napolitano, Stefania, et al.
Publicado: (2020)

Core Clinical Phenotypes in Myotonic Dystrophies
por: Wenninger, Stephan, et al.
Publicado: (2018)

Inhibition of voltage-gated sodium channels by sumatriptan bioisosteres
por: Carbonara, Roberta, et al.
Publicado: (2015)

Blockers of Skeletal Muscle Na(v)1.4 Channels: From Therapy of Myotonic Syndrome to Molecular Determinants of Pharmacological Action and Back
por: De Bellis, Michela, et al.
Publicado: (2023)

Cells of Matter—In Vitro Models for Myotonic Dystrophy
por: Matloka, Magdalena, et al.
Publicado: (2018)

Chaperone activity of niflumic acid on ClC-1 chloride channel mutants causing myotonia congenita
por: Altamura, Concetta, et al.
Publicado: (2022)

The Era of Precision Medicine: Reshaping Usher Syndrome
por: Jung, Jinsei
Publicado: (2020)

Muscle wasting in myotonic dystrophies: a model of premature aging
por: Mateos-Aierdi, Alba Judith, et al.
Publicado: (2015)

Understanding the Precision in “Precision Medicine”
por: Chabner, Bruce A.
Publicado: (2016)

A step ahead toward precision medicine for chronic lymphocytic leukemia
por: Patriarca, Andrea, et al.
Publicado: (2020)

Molecular Insights into the Local Anesthetic Receptor within Voltage-Gated Sodium Channels Using Hydroxylated Analogs of Mexiletine
por: Desaphy, Jean-François, et al.
Publicado: (2012)

Functional characterization of ClC-1 mutations from patients affected by recessive myotonia congenita presenting with different clinical phenotypes()
por: Desaphy, Jean-François, et al.
Publicado: (2013)

Myotonic Dystrophy: From Molecular Pathogenesis to Therapeutics
por: Timchenko, Lubov
Publicado: (2022)

Precision Medicine
por: Pinho, João Renato Rebello
Publicado: (2017)

Precision medicine()
por: Nakanishi, Marcio
Publicado: (2018)

Translational approach to address therapy in myotonia permanens due to a new SCN4A mutation
por: Desaphy, Jean-François, et al.
Publicado: (2016)

Myotonic Dystrophies: State of the Art of New Therapeutic Developments for the CNS
por: Gourdon, Genevieve, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_hpljpbksjof39dlue910qpl0ik